DBIBB
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-117779-5MG | 5 mg | 235,00 | Add | |
| HY-117779-1ML | 10mM/1mL | 258,00 | Add | |
| HY-117779-10MG | 10 mg | 368,00 | Add | |
| HY-117779-25MG | 25 mg | 723,00 | Add | |
| HY-117779-50MG | 50 mg | 1'153,00 | Add | |
| HY-117779-100MG | 100 mg | 1'838,00 | Add | |
| HY-117779-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
DBIBB is a specific nonlipid agonist of the type 2 G protein coupled receptor for lysophosphatidic acid (LPA2). DBIBB mitigates the gastrointestinal radiation syndrome, increases intestinal crypt survival and enterocyte proliferation, and reduces apoptosis. DBIBB represents a agent candidate capable of mitigating acute radiation syndrome caused by high-dose γ-radiation to the hematopoietic and gastrointestinal system[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Endocrinology, Apoptosis |
| Format | Solubility: DMSO : ≥ 100 mg/mL |
| Grade | Clinical information: No Development Reported |
| Purity | 99.07% |
| Molecular Formula | C23H20N2O6S |
| Molecular Weight | 452.48 |
| CAS-Number | 1569309-92-7 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
